Matinas BioPharma Holdings Inc (NYSEAMERICAN:MTNB) was the recipient of a significant decline in short interest in April. As of April 30th, there was short interest totalling 4,610,838 shares, a decline of 14.4% from the April 15th total of 5,388,329 shares. Currently, 3.9% of the company’s stock are sold short. Based on an average daily volume […]
